Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesCardiologyDevoted Health ZOLL HFMS Coverage | OpenPayer
    Ask Trek AI about this page
    CurrentDevoted HealthPolicy UMGT.CL.0003

    ZOLL Heart Failure Management System Coverage

    Customize your policy alerts

    Sign up for devoted_health Policy UMGT.CL.0003 alerts

    Get alerted when Policy UMGT.CL.0003 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy applies to all Devoted Health plans and addresses coverage of the ZOLL Heart Failure Management System (HFMS), also called the µCor System. The device and associated monitoring services are investigational and non-covered.

    Policy Summary
    PayerDevoted Health
    PolicyZOLL Heart Failure Management System Coverage
    Policy CodePolicy UMGT.CL.0003
    Change TypeClarificationno material clinical or coverage change
    Effective DateOctober 15, 2024
    Next Review DateOctober 15, 2026
    Key ActionClaims for the ZOLL HFMS and its associated remote monitoring services are at risk of denial because the system is considered investigational, experimental, and unproven.
    SourceLink
    POLICY UPDATE CHANGES

    The non-coverage language for the ZOLL HFMS was edited in the version history.

    All plansApplicability
    Non-coveredCoverage stance
    2Monitoring codes
    3Clinical trials

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    510(k)
    FDA clearance

    ZOLL HFMS Coverage Criteria

    ZOLL HFMS Non-Coverage

    Devoted Health considers the ZOLL Heart Failure Management System (HFMS), also called the µCor System, investigational and non-covered because sufficient clinical evidence does not support its use.

    • The ZOLL HFMS (µCor System) is not covered by Devoted Health. It is considered investigational, experimental, and unproven because there is insufficient clinical evidence to support its use.
    • The ZOLL HFMS is a non-invasive, patch-based device that uses radiofrequency technology to detect early changes in pulmonary fluid levels, which may indicate heart failure decompensation. It also records, stores, and transmits heart rate, respiration rate, activity, posture, and heart rhythm (ECG) data that may be used to inform care plans.
    • There is little published, peer-reviewed literature supporting the device. Two manufacturer-sponsored clinical trials submitted completed study results in 2024; one posted an overview of results, while the second trial was under Quality Control Review as of September 25, 2024. Both studies collected data from patients who wore the sensor for three months. Additional trials and studies are needed to establish long-term efficacy and performance compared with current monitoring standards.
    • A 2025 cost-effectiveness analysis by Bosworth-Smith et al. compared the ZOLL HFMS with standard of care in the United States using a five-year Markov model following patients after discharge from an index hospitalization for heart failure. The model estimated a mean reduction in cost of care of $6,723 with ZOLL HFMS compared with standard of care; however, the authors encouraged additional long-term data to confirm or contest these modeled outcomes and determine whether reduced hospital readmissions alleviate the burden of heart failure.
    • The ZOLL HFMS received FDA 510(k) clearance on May 11, 2018, under K172510. FDA clearance does not establish coverage under this policy.

    Applicable Codes

    Applicable codesCPTNot Covered
    0607TRemote monitoring of an external continuous pulmonary fluid monitoring system, including measurement of radiofrequency-derived pulmonary fluid levels, heart rate, respiration rate, activity, posture, and cardiovascular rhythm (eg, ECG data), transmitted to a remote 24-hour attended surveillance center; set-up and patient education on use of equipment
    0608Tanalysis of data received and transmission of reports to the physician or other qualified health care professional

    Provider and Billing Guidance

    Denial Risk

    ZOLL HFMS claims may be denied

    Claims for the ZOLL HFMS (µCor System) and its associated remote monitoring services are at risk of denial because Devoted Health considers the system investigational, experimental, and unproven, with insufficient clinical evidence to support its use. The ZOLL HFMS is therefore non-covered.

    • This applies to remote monitoring services billed for the ZOLL HFMS.
    • Applicable procedure codes include 0607T and 0608T.

    Technology Overview

    The ZOLL Heart Failure Management System (HFMS), also called the µCor System, is a non-invasive, patch-based device that uses radiofrequency technology to detect changes in pulmonary fluid levels. An increase in pulmonary fluid may indicate early heart failure decompensation. The system also records, stores, and transmits heart rate, respiration rate, activity, posture, and heart rhythm (ECG) data to help inform care plans.

    Key Terms

    ZOLL Heart Failure Management System (HFMS) / µCor System
    Device typeNon-invasive, patch-based device
    TechnologyUses radiofrequency technology
    Primary monitoring functionDetects changes in pulmonary fluid levels for early indication of heart failure decompensation
    Additional data collectedRecords, stores, and transmits heart rate, respiration rate, activity, posture, and heart rhythm (ECG) data
    Abbreviation
    UMUtilization Management
    Policy Summary
    PayerDevoted Health
    PolicyZOLL Heart Failure Management System Coverage
    Policy CodePolicy UMGT.CL.0003
    Change TypeClarificationno material clinical or coverage change
    Effective DateOctober 15, 2024
    Next Review DateOctober 15, 2026
    Key ActionClaims for the ZOLL HFMS and its associated remote monitoring services are at risk of denial because the system is considered investigational, experimental, and unproven.
    SourceLink
    On This Page
    ZOLL HFMS Coverage CriteriaApplicable CodesProvider and Billing GuidanceTechnology OverviewKey Terms